Pharmaceutical Supply of Vecuronium Bromide

The contract calls for the supply of Vecuronium Bromide in finished dosage form, packaged in units of 10 per package, adhering strictly to FDA, USP, and Defense Logistics Agency technical specifications. This includes compliance with required shelf-life durations, approved storage conditions, and military-grade packaging standards to ensure product integrity during transport and long-term storage in defense logistics environments. The product must meet all regulatory and operational criteria established for use within the Department of Defense medical supply chain. Issued under the NAICS code 325412 for pharmaceutical manufacturing, this subcontract is managed by the Medical Supply Chain Pharm FSA under the Department of Defense, with a response deadline of May 18, 2026, and a posted date of May 13, 2026. The contract is part of a broader effort to secure critical pharmaceuticals for military medical operations and requires full alignment with federal and defense-specific quality and packaging protocols. All deliveries must be traceable, compliant, and ready for immediate deployment under military supply chain conditions.